GINKGO BIOWORKS HOLDINGS, INC. Deferred Foreign Income Tax Expense (Benefit)
GINKGO BIOWORKS HOLDINGS, INC. (DNA) reported Deferred Foreign Income Tax Expense (Benefit) of -$1.36 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredForeignIncomeTaxExpenseBenefit · last filed 2026-02-26
- GINKGO BIOWORKS HOLDINGS, INC. deferred foreign income tax expense (benefit) for fiscal 2025 was -$1.36M.
- GINKGO BIOWORKS HOLDINGS, INC. deferred foreign income tax expense (benefit) for fiscal 2024 was -$936.00K.
- GINKGO BIOWORKS HOLDINGS, INC. deferred foreign income tax expense (benefit) for fiscal 2023 was -$884.00K.
- GINKGO BIOWORKS HOLDINGS, INC. deferred foreign income tax expense (benefit) for fiscal 2022 was -$1.01M.
| Period end | Deferred Foreign Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | -$1.36M 10-K · filed 2026-02-26 |
| 2024-12-31 | -$936.00K 10-K · filed 2026-02-26 |
| 2023-12-31 | -$884.00K 10-K · filed 2026-02-26 |
| 2022-12-31 | -$1.01M 10-K · filed 2025-02-25 |
| 2021-12-31 | -$156.00K 10-K · filed 2024-02-29 |
| 2020-12-31 | $0.00 10-K · filed 2023-03-13 |
| 2019-12-31 | $0.00 10-K · filed 2022-03-29 |